Robin Readnour

Robin S.
Readnour is Chairman & Chief Executive Officer at Borah LLC, Chief Executive Officer at Borah, Inc., Chairman at In The Bowl Animal Health Inc since 2014, Executive Chairman at Bowl Animal Health, Inc., Director at Biotechnology Innovation Organization, Director at Advanced Animal Diagnostics, Inc. since 2021, Managing Director at Mountain Group Partners LLC since 2018, Director at Nusirt Sciences, Inc., Director at Skyline Vet Pharma, Inc., Director at Appello Pharmaceuticals, Inc., Director at TARGAN, Inc. since 2019, Independent Director at AN2 Therapeutics, Inc. since 2019, Director at Exubrion Therapeutics, Inc., Director at Vytelle LLC, and Director at Verility, Inc. Former roles include Senior Director-Product Development at Eli Lilly & Co., Director at Velo One Ltd., Senior Director-Product Development at Elanco Animal Health, Inc. from 2017 to 2018, Member-Food & Agriculture Section at Bio Internationals Ltd., and Chief Scientific Officer at Elanco Alternative Innovation from 2017 to 2018.
Education includes undergraduate studies at Southeast Missouri State University and a doctorate from the University of Illinois conferred in 1990.